---
title: "MetaVia says all active patients reach highest target doses in DA-1726 obesity Phase 1 Part 3 study"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292199242.md"
description: "MetaVia announced that all active patients in Part 3 of its Phase 1 obesity trial for DA-1726 reached the highest target doses. Two cohorts successfully completed titration to 48 mg and 64 mg, supporting a favorable tolerability profile at higher doses. Topline results from these 16-week titration cohorts are scheduled for release in the fourth quarter of 2026."
datetime: "2026-07-09T12:33:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292199242.md)
  - [en](https://longbridge.com/en/news/292199242.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292199242.md)
generator: "portal-rs"
---

# MetaVia says all active patients reach highest target doses in DA-1726 obesity Phase 1 Part 3 study

-   MetaVia reached its highest target doses in all active patients in Part 3 of its Phase 1 obesity trial for DA-1726. \* Two cohorts completed titration to 48 mg and 64 mg, supporting a tolerability profile at higher doses. \* Topline results from the 16-week titration cohorts remain scheduled for the fourth quarter of 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metavia Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607090831PR\_NEWS\_USPR\_\_\_\_\_NY00432) on July 09, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [MTVA.US](https://longbridge.com/en/quote/MTVA.US.md)

## Related News & Research

- [MetaVia Advances DA-1726 Obesity Trial to Top Doses](https://longbridge.com/en/news/292215429.md)
- [Livetech da Bahia controller raises stake by R$ 23,949 via on-market buys](https://longbridge.com/en/news/297960883.md)
- [Banco Santander Brasil officer Marcos Jose Maia da Silva buys common shares worth USD 43,356.24](https://longbridge.com/en/news/297699862.md)
- [CF Industries announces dividend of R$ 2.09 per unit for Q3 2026](https://longbridge.com/en/news/297814811.md)
- [Cruzeiro do Sul Educacional announces extraordinary shareholder meeting](https://longbridge.com/en/news/297516717.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**